T3SS-IN-5
Product Specifications
UNSPSC Description
T3SS-IN-5 (Compound F9) is a specific inhibitor of the type III secretion system (T3SS). T3SS-IN-5 reduces bacterial pathogenicity without affecting bacterial viability by inhibiting the expression of genes associated with T3SS[1].
Target Antigen
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/t3ss-in-5.html
Solubility
10 mM in DMSO
Smiles
OC(C1=NN=C(SCC2=CC=CC=C2)S1)C3=CC=CC=C3
Molecular Weight
314.43
References & Citations
[1]Zhang YQ, et al. Design and Synthesis of Mandelic Acid Derivatives for Suppression of Virulence via T3SS against Citrus Canker. J Agric Food Chem. 2024 May 1;72(17):9611-9620.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-158320/T3SS-IN-5-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-158320/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![TLR7 Mouse Monoclonal Antibody [Clone ID: 4G6]](https://cdn.genprice.uk/genprice/genprice2.png)
MBS6475231-01 0.1 mL
EIF2AK3, CT (Eukaryotic Translation Initiation Factor 2-alpha Kinase 3, PRKR-like Endoplasmic Reticulum Kinase, Pancreatic eIF2-alpha Kinase, HsPEK, PEK, PERK) (MaxLight 650)
Ask
View Details MBS6475231-02 5x 0.1 mL
EIF2AK3, CT (Eukaryotic Translation Initiation Factor 2-alpha Kinase 3, PRKR-like Endoplasmic Reticulum Kinase, Pancreatic eIF2-alpha Kinase, HsPEK, PEK, PERK) (MaxLight 650)
Ask
View Details MBS1487629-01 0.02 mg (E-Coli)
Recombinant Takifugu rubripes Homeobox protein Hox-D9a (hoxd9a)
Ask
View Details